Medea Medical

About Medea Medical

Medea Medical is on the verge of certifying its collagen-based hemostatic agent, Novacol®, under the new CE-MDR regulations. What sets Novacol® apart is not merely its hemostatic function, but its ability to eliminate two critical risks: swelling and slow resorption. Swelling poses an immediate threat to surrounding tissue, particularly in neurosurgery, while slow resorption increases the risk of postoperative infections. Novacol® offers a safe, rapidly resorbable alternative at a competitive price. The upcoming phase focuses on scaling up: building inventory, establishing an efficient supply chain, and launching new sales and distribution channels across multiple international key markets.

Keywords

• 3 Times Faster Then Orc
• Antigen Tests
• Bovine Collagen
• Covid-19 Tests
• Fastest Resorption
• Hemostasis
• Ivd Tests
• Medical Device Manufacturing
• Neurosurgery
• No Swelling
• Rapid Tests

Address

• Headquarters

  Industrieweg 2a2631PG NootdorpZuid-Holland, Netherlands

Team by function

Based on 6 public job profiles as of 4 September 2026.

• Other / Unclassifiable2
• Sales2
• Administrative / Office1
• Logistics / Transportation1